During the past decade, Futata Tetsuhiro Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Futata Tetsuhiro Clinic" are "Diabetes Mellitus" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Endocrine System Diseases" (1 trials), "Glucose Metabolism Disorders" (1 trials) and "Hypoglycemic Agents" (1 trials). Many other conditions were trialed in "Futata Tetsuhiro Clinic" in a lesser frequency.

Most popular intervention types in "Futata Tetsuhiro Clinic" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (2 trials), "Tirzepatide" (2 trials), "Alpha-Glucosidase Inhibitors (α-GI)" (1 trials), "Biguanide (BG)" (1 trials) and "Glinides (GLN)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Futata Tetsuhiro Clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Futata Tetsuhiro Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Futata Tetsuhiro Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Futata Tetsuhiro Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".